Elekta’s Leksell Gamma Knife® Icon™, the next generation in stereotactic radiosurgery (“SRS”) technology has been installed at the Queen Square Radiosurgery Centre.

The centre is one of two NHS England (“NHSE”) National Centres of Excellence providing specialist care and support for patients including those with rare and complex conditions and is located at the National Hospital for Neurosurgery and Neurology, part of the University College London Hospitals NHS Foundation Trust (“UCLH”).

Leksell Gamma Knife is the leading SRS system designed specifically to target brain tissue offering proven accuracy in both the location and radiation dose delivered to targeted brain tissue. Icon is the sixth generation of the Leksell Gamma Knife system, resulting from Elekta’s extensive history in SRS technology and decades of collaboration with neurosurgeons and radiation oncologists around the world. You can think of it as the “new and improved” version of the Gamma Knife Perfexion first installed at the centre in 2012, in that it builds off what was already a high regarded sytem preferred by experts worldwide.

Elekta’s Leksell Gamma Knife® Icon™ at the Queen Square Gamma Knife Centre

Although it sounds like surgery, Gamma Knife radiosurgery is minimally invasive, does not involve any incisions and does not require a hospital stay. In contrast to traditional whole brain radiation therapy that exposes the entire brain to low doses of radiation over multiple sessions, Gamma Knife radiosurgery uses multiple beams of radiation at the same time to treat just the targeted area. This allows for higher doses of radiation to be delivered each treatment and as a result, patients require fewer treatment sessions. Furthermore, healthy surrounding tissues receive less radiation, resulting in fewer of the unpleasant side effects often associated with radiation therapy and improved clinical outcomes.

Since it is an outpatient procedure, Gamma Knife radiosurgery does not require a hospital stay and offers significant benefits to patients. Similarly, thanks to its minimally invasive nature, Gamma Knife also eliminates the risks associated with general surgery, and most patients are able to return to normal activities within a day, rather than weeks or even months.

Icon provides the flexibility for single dose administration or multiple treatment sessions over time. Clinicals still have the option of delivering a single large dose, as with the Gamma Knife Perfexion or smaller doses in multiple sessions in what is referred to as fractionated radiosurgery. This widens the range of indications that can be treated to include larger malignant tumours.

Many patients will have the option of a custom face mask as opposed to the headframe, which some people prefer. However, this will depend on their specific condition and the characteristics of the area being treated, such as size and location.

“UCLH has a comprehensive suite of the latest innovative technologies to treat patients with cranial tumours and other indications that the health service will be able to rely on in the years to come” said Kevin Sullivan, Divisional Manager, Cancer Services at UCLH. “We are pleased to work in partnership with Medical Equipment Solutions Ltd delivering the South of England NHSE Stereotactic Radiosurgery Supra Centre and welcome their investment in upgrading to a Gamma Knife ICON which adds to the armamentarium available to our clinicians and offers opportunities for considerable benefits for patients”.

“As a national centre of excellence it is important that we continue to have the latest technology available to us” said Mr Neil Kitchen, Consultant Neurosurgeon and Clinical Director of the Queen Square Gamma Knife Centre. “The Icon system expands our options to meet patient-specific needs. It provides the unrivalled precision and accuracy for which Gamma Knife has long been known and gives us the flexibility to deliver treatment in single or multiple sessions. This expands the range of indications that we can treat to include larger tumours and offers frameless treatment for some patients”.

Lynne Brooks, CEO of Medical Equipment Solutions Ltd said “In the 70th anniversary year since the formation of the National Health Service we are proud to work in partnership with UCLH ensuring that the latest technology underpins the NHSE SRS Supra Centre for the South of England. The installation of a Gamma Knife ICON represents yet another important landmark in the development of the centre which grows from strength to strength, making a real difference for patients and their families and is contributing towards the implementation of NHS England’s Cancer Strategy”.

“Elekta’s Leksell Gamma Knife® Icon™ is the only dedicated intracranial solution on the market, and over 75 leading health centres around the world recognise the safety, efficacy and comfort benefits that the system provides to patients.” said Steve Tomkins, Elekta’s UK, Ireland & Nordics Business Unit Manager. “We welcome the investment Queen Square Gamma Knife has made in a new Icon and are proud to continue to working with Medical Equipment Solutions Ltd, with whom we have worked over the last decade in to increase access to advanced radiotherapy in the UK”.


About the Queen Square Gamma Knife Centre

The Centre is owned and operated by Medical Equipment Solutions Ltd via its subsidiary QSRC Ltd. The centre enjoys a significant number of strengths from the well established integration with other areas of expertise within UCLH and is located at The National Hospital for Neurology and Neurosurgery, the UK’s largest dedicated neurological and neurosurgical hospital. In 2016 a partnership with UCLH, was successful in becoming one of only two NHS England centres of excellence (Supracentres) for stereotactic radiosurgery/radiotherapy. As well as providing specialist care and support for patients, including those with rare and complex conditions, the centre also undertakes and active programme of research. www.queensquaregammaknife.co.uk


About UCLH

UCLH provides first-class acute and specialist services in five hospitals in central London including The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, the UK’s largest dedicated neurological and neurosurgical hospital. UCLH’s mission is to deliver top-quality patient care, excellent education and world-class research. In partnership with University College London (UCL) they are one of the country’s five comprehensive biomedical research centres and are a member of UCL Partners  that brings  together some of the UK’s world-renowned medical research centres and hospitals. www.uclh.nhs.uk

About Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Their advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Their treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. www.elekta.com.

For more information please contact Lynne Brooks, CEO, The Queen Square Gamma Knife Centre
Tel: 01372 362673
e-mail: [email protected]